Summary
The highly vesicant nature of the alkylating anticancer agent mechlorethamine (HN2, or nitrogen mustard) requires careful i. v. technique during its administration. Skin toxicity due to HN2 extravasation is severe and typically prolonged over several months. Mouse skin toxicity studies were carried out to find a local antidote to decrease the severity of tissue damage by this agent. Intradermal (i.d.) HN2 (0.005–0.5 mg) caused dose-dependent skin ulcers in the mouse. Isotonic sodium thiosulfate Na2S2O3 (0.167 M) or hypertonic (0.34 M) Na2S2O3 (0.05 ml) given immediately after HN2 significantly reduced the mean HN2 ulceration area and the total time of ulceration. Ineffective local HN2 antidotes included hyaluronidase, hydrocortisone, and sodium chloride, all given i.d. Topical applications of DMSO, cold, and heat were also ineffective. Sodium thiosulfate is believed to chemically neutralize reactive mechlorethamine-alkylating species and thus decrease skin toxicity. Thiosulfate dosing studies showed that a molar excess of at least 200:1 (Na2S2O3:HN2) was required for significant antidotal activity. If thiosulfate treatment was delayed 4–24 h after HN2, no antidotal effects were obtained. We conclude that sodium thiosulfate can decrease the severity of local tissue damage caused by HN2. It should be considered the antidote of choice in the setting of clinical HN2 extravasations.
Similar content being viewed by others
References
Bonadonna G, Karnofsky DA (1965) Protection studies with sodium thiosulfate against methyl bis (B-chloroethyl) amince hydrochloride (HN2) and its ethyleimmonium derivative. Clin Pharmacol Ther 6(1): 50–64
Calabresi P, Parks RE (1975) Alkylating agents, antimetabolites, hormones, and other antiproliferative agents. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 1254–1262
Chait LA, Dinner MI (1975) Ulceration caused by cytotoxic drugs. S Afr Med J 49: 1935–1936
Dorr RT, Alberts DS, Chen HSG (1980) Experimental model of doxorubicin extravasation in the mouse. J Pharmacol Methods 4(4): 321–334
Dorr RT, Alberts DS, Stone A (1985) Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. Cancer Treat Rep 69: 431–437
Gilman A (1963) The initial clinical trial of nitrogen mustard. Am J Surg 105: 574–578
Goodman L, Wintrobe M, Dameshek W, Goodman MJ, Gilman A, McLennan MT (1946) Nitrogen mustard therapy. J Am Med Assoc 132(3): 126–132
Hatiboglu I, Mihich E, Moore GE, Nichol CA (1962) Use of sodium thiosulfate as a neutralizing agent during regional administration of nitrogen mustard: An experimental study. Ann Surg 156(6): 994–1001
Litwins J, Boyd JJ, Greenwald L (1943) Action of sodium thiosulfate on blood. Exp Med Surg 1: 252–259
Merck, Sharpe and Dohme Company, Mustargen official prescribing information. (1985) Physician desk reference, 39th edn. Medical Economics Co, Oradell, NJ, pp 1337–1339
Nie NH, Hill CH, Jenkins JG, Steinbrenner K, Bent DH (1975) Statistical packages for the social services. McGraw-Hill, New York, pp 422–430
Ogston A, Holiday J, Philpot J, Stocken LA (1984) The replacement reactions of beta dichlorethyl sulphide and of some analogous in aqueous solution: The isolation of beta chloro beta hydroxyl diethyl sulphide. Trans Faraday Soc 44: 45
Owen OE, Dellatorre DL, Van Scott EJ, Cohen MR (1980) Accidental intramuscular injection of mechlorethamine. Cancer 45: 2225–2226
Owens G, Hatiboglu I (1961) Clinical evaluation of sodium thiosulfate, a systemic neutralizer of nitrogen mustard. Ann Surg 154: 895–897
Shea M, Koziol JA, Howell SB (1984) Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther 35(3): 419–425
Van Scott EJ, Kimanson JD (1973) Complete remission of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Cancer 32: 18–30
Author information
Authors and Affiliations
Additional information
Supported in part by Public Health Service Grants CA-31078, CA-23074, and CA-17094 from the National Cancer Institute; National Institute of Health, Department of Health and Human Services, Bethesda, MD
Rights and permissions
About this article
Cite this article
Dorr, R.T., Soble, M. & Alberts, D.S. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse. Cancer Chemother. Pharmacol. 22, 299–302 (1988). https://doi.org/10.1007/BF00254235
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254235